SCHEMBL8670655

SCHEMBL8670655

CCOc1cccc([CH]Cc2cccc(OCC)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CHRM2 P08172 1/20 0.48
CHRM1 P11229 1/20 0.48
CHRM3 P20309 1/20 0.48
MAOA P21397 7/20 0.47
MAOB P27338 7/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
DHFR P00374 1/20 0.43
RELA Q04206 1/20 0.42
LCK P06239 1/20 0.42
TSHR P16473 1/20 0.42
HDAC4 P56524 1/20 0.41
MEF2D Q14814 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8674540 0.82 MAOB (0.71) KDM4EALDH1A1MAOAMAOBNPC1
SCHEMBL7321393 0.81 KDM4E (0.55) SMN1; SMN2KDM4EALDH1A1CHRM2CHRM1
SCHEMBL6181647 0.81 CHRM2 (0.59) SMN1; SMN2KDM4EALDH1A1CHRM2CHRM1
SCHEMBL8670249 0.81 MAOA (0.45) KDM4EALDH1A1MAOAMAOBCYP3A4
SCHEMBL493931 0.79 MAOA (0.62) SMN1; SMN2KDM4EALDH1A1CHRM2CHRM1
SCHEMBL29432706 0.79 MAOA (0.62) SMN1; SMN2KDM4EALDH1A1CHRM2CHRM1
SCHEMBL8671069 0.78 TLR4 (0.54) MAOAMAOB
SCHEMBL5247739 0.78 KDM4E (0.60) SMN1; SMN2KDM4EALDH1A1CHRM2CHRM1
SCHEMBL28886740 0.78 TP53 (0.53) SMN1; SMN2KDM4EALDH1A1CHRM2CHRM1
Benzene SCHEMBL27795602 0.77 MAOA (0.65) SMN1; SMN2KDM4EALDH1A1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed